Musunuri Shankar — SEC insider filings
SEC reporting owner CIK 1791820. 24 insider filings on record with FilingPulse; latest filed 2026-10-13.
Transaction summary — filings shown
Covers all 24 filings on record, filed 2021-01-04 to 2026-10-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 20 legs across 17 filings — 2,716,348 shares, $11,275,119 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 42.
- Largest priced transaction: sale of 195,809 shares @ $14.24 ($2,788,320) in Ocugen, Inc., filed 2021-05-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Ocugen, Inc. (OCGN) | Chief Executive Officer, Director | 24 | — | 20 legs · 2,716,348 sh · $11,275,119 | 42 |
Insider filings — Musunuri Shankar
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-13 | 4 | Ocugen, Inc. (OCGN) | Sale (S): 468,727 @ $0.95 · Sale (S): 57,264 @ $0.95 | EDGAR |
| 2026-09-11 | 4 | Ocugen, Inc. (OCGN) | Sale (S): 468,727 @ $1.12 · Sale (S): 57,264 @ $1.12 | EDGAR |
| 2026-01-06 | 4 | Ocugen, Inc. (OCGN) | Grant/award (A): 3,123,201 @ $0 · Grant/award (A): 3,123,201 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Ocugen, Inc. (OCGN) | Tax withholding (F): 177,146 @ $0.89 · Grant/award (A): 1,827,485 (derivative) @ $0 | EDGAR |
| 2024-01-05 | 4 | Ocugen, Inc. (OCGN) | Tax withholding (F): 180,204 @ $0.65 | EDGAR |
| 2024-01-04 | 4 | Ocugen, Inc. (OCGN) | Grant/award (A): 492,126 (derivative) @ $0 | EDGAR |
| 2023-02-17 | 4 | Ocugen, Inc. (OCGN) | Tax withholding (F): 37,877 @ $1.25 · Option exercise (M): 100,000 @ $0.33 · Sale (S): 100,000 @ $1.08 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2023-01-19 | 4 | Ocugen, Inc. (OCGN) | Option exercise (M): 100,000 @ $0.51 · Sale (S): 100,000 @ $1.28 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Ocugen, Inc. (OCGN) | Grant/award (A): 1,475,410 @ $0 · Grant/award (A): 1,771,654 (derivative) @ $0 | EDGAR |
| 2022-12-20 | 4 | Ocugen, Inc. (OCGN) | Option exercise (M): 95,809 @ $0.51 · Sale (S): 95,809 @ $1.43 · Option exercise (M): 95,809 (derivative) @ $0 | EDGAR |
| 2022-10-14 | 4 | Ocugen, Inc. (OCGN) | Option exercise (M): 100,000 @ $0.51 · Sale (S): 100,000 @ $1.66 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2022-07-15 | 4 | Ocugen, Inc. (OCGN) | Option exercise (M): 150,000 @ $0.33 · Sale (S): 150,000 @ $2.72 · Option exercise (M): 150,000 (derivative) @ $0 | EDGAR |
| 2022-05-13 | 4 | Ocugen, Inc. (OCGN) | Option exercise (M): 125,000 @ $0.33 · Sale (S): 125,000 @ $1.92 · Option exercise (M): 125,000 (derivative) @ $0 | EDGAR |
| 2022-03-18 | 4 | Ocugen, Inc. (OCGN) | Option exercise (M): 81,823 @ $0.33 · Sale (S): 81,823 @ $2.65 · Option exercise (M): 81,823 (derivative) @ $0 | EDGAR |
| 2022-02-16 | 4 | Ocugen, Inc. (OCGN) | Option exercise (M): 90,000 @ $0.33 · Sale (S): 90,000 @ $3.74 · Option exercise (M): 90,000 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | Ocugen, Inc. (OCGN) | Grant/award (A): 346,540 @ $0 · Grant/award (A): 1,253,299 (derivative) @ $0 | EDGAR |
| 2021-12-17 | 4 | Ocugen, Inc. (OCGN) | Sale (S): 115,000 @ $5.22 · Grant/award (A): 197,000 (derivative) @ $0 | EDGAR |
| 2021-11-18 | 4 | Ocugen, Inc. (OCGN) | Sale (S): 115,000 @ $8.04 · Grant/award (A): 197,000 (derivative) @ $0 | EDGAR |
| 2021-11-03 | 4 | Ocugen, Inc. (OCGN) | Option exercise (M): 115,367 @ $0.51 · Sale (S): 115,367 @ $14.15 · Option exercise (M): 115,367 (derivative) @ $0 | EDGAR |
| 2021-10-15 | 4 | Ocugen, Inc. (OCGN) | Option exercise (M): 125,000 @ $0.33 · Sale (S): 125,000 @ $9.80 · Option exercise (M): 125,000 (derivative) @ $0 | EDGAR |
| 2021-09-17 | 4 | Ocugen, Inc. (OCGN) | Option exercise (M): 125,000 @ $0.33 · Sale (S): 125,000 @ $7.52 · Option exercise (M): 125,000 (derivative) @ $0 | EDGAR |
| 2021-06-09 | 4 | Ocugen, Inc. (OCGN) | Option exercise (M): 7,758 @ $0.33 · Sale (S): 7,758 @ $10.94 · Option exercise (M): 22,800 @ $0.33 · Sale (S): 22,800 @ $10.98 · Option exercise (M): 7,758 (derivative) @ $0 · Option exercise (M): 22,800 (derivative) @ $0 | EDGAR |
| 2021-05-03 | 4 | Ocugen, Inc. (OCGN) | Option exercise (M): 195,809 @ $0.51 · Sale (S): 195,809 @ $14.24 · Option exercise (M): 195,809 (derivative) @ $0 | EDGAR |
| 2021-01-04 | 4 | Ocugen, Inc. (OCGN) | Grant/award (A): 1,757,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-12-17 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1791820 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs